Has Michael Phillips, MD received payments from drug or device companies?

Yes. Drug and device makers reported $30,143 in general payments to Michael Phillips, MD across 549 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Michael Phillips, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Michael Phillips, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Michael Phillips, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Tulsa, OKNPI 1619904513

Payments from drug & device makers

$30,143in general payments, 2019–2025

Across 549 payments — averaging $54.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$8K
Abiomed$3K
Inari Medical, Inc.$2K
Silk Road Medical, Inc.$2K
Atricure, Inc.$2K
Edwards Lifesciences$2K
plus $10K from 48 others

What the payments were for

Consulting fees$290%
Travel & lodging$1,5895%
Food & beverage$28,52495%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic(2 entities)	206	$8,381
Abiomed	33	$2,740
Inari Medical, Inc.	23	$2,406
Silk Road Medical, Inc.	26	$2,291
Atricure, Inc.	36	$2,221
Edwards Lifesciences	26	$1,671
Abbott	22	$1,561
Johnson & Johnson(3 entities)	42	$1,511
Endologix LLC	10	$1,323
Intuitive Surgical	15	$1,289
W. L. Gore & Associates, Inc.	8	$717
Bolton Medical Inc	8	$543
Baxter Healthcare	9	$361
Davol Inc.	6	$337
Shockwave Medical, Inc	3	$331
Clearflow Inc.	1	$311
Angiodynamics, Inc.	3	$268
Elutia, Inc.	3	$210
Octapharma USA, Inc.	4	$180
Penumbra, Inc.	3	$160
Cordis US CORP.	1	$135
Cook Medical LLC	8	$115
Terumo Cardiovascular Systems Corporation	1	$69
GE HealthCare	2	$62
Hemosonics LLC	2	$61
Chiesi USA, Inc.	4	$58
Nuwellis, Inc.	3	$57
Getinge USA Sales, LLC	2	$57
Artivion, Inc.	2	$57
Boston Scientific	2	$50
Surmodics, Inc.	2	$47
Avanos Medical	3	$47
Kls-martin L.p.	3	$47
Lilly USA, LLC	2	$41
Livanova USA, Inc.	2	$41
Portola Pharmaceuticals, LLC	2	$30
Z-medica, LLC	2	$29
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	2	$27
Smith+Nephew	1	$27
Pylant Medical	1	$24
La Jolla Pharmaceutical Company	2	$23
Asahi Intecc USA, Inc.	1	$23
Biomerieux Inc	1	$22
BD	1	$20
Grifols USA, LLC	1	$19
Melinta Therapeutics, LLC	1	$19
Cagent Vascular Inc	1	$18
Teleflex LLC	1	$18
Hologic Sales And Service, LLC	1	$17
Zimmer Biomet	1	$16
AstraZeneca	1	$15
TELA Bio, Inc.	1	$14
Covidien LP	1	$12
Trevena, Inc.	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

ENDURANT IIS$2,455
ENROUTE Transcarotid Neuroprotection System$1,787
Impella$1,431
Endurant$1,425
FLOWTRIEVER CATHETER, S$1,290
ENROUTE Transcarotid Stent$1,261
FlowTriever$1,084
ClotTriever$1,084
ENHANCE Transcarotid Peripheral Access Kit$1,046
Da Vinci Surgical System$913
CT THROMBECTOMY SYSTEM KIT$727
Tendyne Mitral Valve System$684
Valiant Captivia$675
SYNERGY ABLATION SYSTEM$570
ENROUTE Transcarotid Stent System$526
ENROUTE 0.014 Guidewire$526
ENROUTE .014 Guidewire$520
EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$483
Alto Abdominal Stent Graft System$420
XARELTO$372

How this compares

$30,143 in reported general payments places this provider in the 80th percentile of 48 thoracic surgery (cardiothoracic vascular surgery) providers in Oklahoma.

See all thoracic surgery (cardiothoracic vascular surgery) providers in Oklahoma →

Medicare billing

Part B allowed, 2024

$197,478

Medicare patients

256

Services billed

566

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
ClopidogrelClopidogrel Bisulfate	32	$330
Mupirocin	23	$152
Oxycodone Hcl	30	$130

Paid to pharmacies, not to this prescriber.

Other thoracic surgery (cardiothoracic vascular surgery) in Tulsa

Matthew CooperTulsa$1.1M
Kelly NagasawaTulsa$46K
Ajit TharakanTulsa$37K
Paul KempeTulsa$18K
John Franco CarabelloTulsa$13K
Robert GarrettTulsa$13K
James NeelTulsa$7K
Shane YamaneTulsa$6K
Kryston BoyerTulsa$4K
David YandellTulsa$4K

See the full list for Oklahoma →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →